+
TBM Kurinji Launched for Corridor 5 Expansion for Chennai Metro
RAILWAYS & METRO RAIL

TBM Kurinji Launched for Corridor 5 Expansion for Chennai Metro

Tata Projects Limited has launched the first Tunnel Boring Machine (TBM) for Corridor 5 of its Phase II expansion project. Named TBM Kurinji, the machine was deployed at the Kolathur Ramp on February 19, 2025, marking a significant milestone in Chennai’s metro development.

Following the successful implementation of Phase I and its extension, CMRL has embarked on an ambitious Phase II expansion, covering 118.9 km across three new corridors, backed by international funding from JICA, ADB, AIIB, and NDB. Corridor 5, spanning 47 km, originates at Madhavaram Milk Colony and passes through key locations such as Koyambedu, Porur, and Alandur, ultimately linking to Shollinganallur. The corridor features five underground stations and 39 elevated stations.

As part of the tunneling strategy, four TBMs, named after Tamil landscapes—Kurinji, Mullai, Marutham, and Neithal—have been designated for Corridor 5. TBM Kurinji will excavate a 246-meter tunnel from Kolathur Ramp towards Kolathur Station (upline), with completion expected by June 2025. It will then be retrieved and relaunched from the south shaft to tunnel towards Srinivasa Nagar (1.06 km). The second TBM, Mullai, is scheduled to arrive by March 2025, commencing tunneling from Villivakkam Railway Station to Villivakkam Bus Terminus, covering 603 meters. The remaining TBMs will be deployed progressively as site conditions permit.

The 7.8 km underground section of Corridor 5 consists of twin tunnels (3.9 km each) extending from Kolathur Ramp to Nathamuni Ramp. Tata Projects Limited, entrusted with executing this critical infrastructure project, is responsible for mobilizing all four TBMs.

With the launch of TBM Kurinji, Chennai’s metro expansion advances further, enhancing urban connectivity and reducing traffic congestion, paving the way for a more efficient and sustainable transit network.

Tata Projects Limited has launched the first Tunnel Boring Machine (TBM) for Corridor 5 of its Phase II expansion project. Named TBM Kurinji, the machine was deployed at the Kolathur Ramp on February 19, 2025, marking a significant milestone in Chennai’s metro development.Following the successful implementation of Phase I and its extension, CMRL has embarked on an ambitious Phase II expansion, covering 118.9 km across three new corridors, backed by international funding from JICA, ADB, AIIB, and NDB. Corridor 5, spanning 47 km, originates at Madhavaram Milk Colony and passes through key locations such as Koyambedu, Porur, and Alandur, ultimately linking to Shollinganallur. The corridor features five underground stations and 39 elevated stations.As part of the tunneling strategy, four TBMs, named after Tamil landscapes—Kurinji, Mullai, Marutham, and Neithal—have been designated for Corridor 5. TBM Kurinji will excavate a 246-meter tunnel from Kolathur Ramp towards Kolathur Station (upline), with completion expected by June 2025. It will then be retrieved and relaunched from the south shaft to tunnel towards Srinivasa Nagar (1.06 km). The second TBM, Mullai, is scheduled to arrive by March 2025, commencing tunneling from Villivakkam Railway Station to Villivakkam Bus Terminus, covering 603 meters. The remaining TBMs will be deployed progressively as site conditions permit.The 7.8 km underground section of Corridor 5 consists of twin tunnels (3.9 km each) extending from Kolathur Ramp to Nathamuni Ramp. Tata Projects Limited, entrusted with executing this critical infrastructure project, is responsible for mobilizing all four TBMs.With the launch of TBM Kurinji, Chennai’s metro expansion advances further, enhancing urban connectivity and reducing traffic congestion, paving the way for a more efficient and sustainable transit network.

Next Story
Infrastructure Urban

Tiger Logistics Q1 FY26 Revenue Up 1.3% to Rs 102.5M

Tiger Logistics (India) Limited announced its unaudited financial results for Q1 FY26, reporting revenue of Rs 102.5 million, a modest year-on-year (YoY) growth of 1.3 per cent. Despite a 10.5 per cent quarter-on-quarter (QoQ) decline due to weaker air transport demand, the company demonstrated resilience with improved profitability.Key Financial Highlights:EBITDA rose 14 per cent YoY to Rs 5.9 million, with margins improving to 5.8 per cent.Profit After Tax (PAT) stood at Rs 4.7 million, up 1.8 per cent YoY.Container volumes grew 6.2 per cent YoY to 18,256 TEUs, while air transport volumes fe..

Next Story
Infrastructure Urban

Biocon Q1 Revenue Hits Rs 39.4 Billion, Up 15 Per Cent

Biocon Limited, a global innovation-driven biopharmaceutical company, reported a consolidated operating revenue of Rs 39.4 billion for the quarter ended 30 June 2025 (Q1 FY26), marking a 15 per cent increase year-on-year. On a like-for-like basis, excluding the divestment gain from the previous year, EBITDA rose 19 per cent to Rs 8.3 billion, while Profit Before Tax (before exceptional items) increased 72 per cent to Rs 970 million.Core EBITDA stood at Rs 10 billion with a 25 per cent margin, supported by strong performances across business segments.Segment Highlights:Biosimilars: Revenue reac..

Next Story
Infrastructure Urban

Pitti Engineering Q1 Revenue Rises 17 per cent to Rs 4.57 Billion

Hyderabad, 7 August 2025 – Pitti Engineering Limited, one of India’s largest producers of electrical steel laminations and machined components, reported robust financial results for the first quarter of FY26, ended 30 June 2025. The company registered a 17 per cent year-on-year rise in revenue to Rs 4.57 billion. EBITDA rose by 30 per cent to Rs 750 million, while profit after tax increased by 17 per cent to Rs 230 million.During the quarter, capacity utilisation reached 82 per cent for machined hours, 70 per cent for sheet metals, and 69 per cent for castings. Sales volume for stator fram..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?